Company

RayThera Inc.

RayThera develops small molecule therapies for immunological conditions.

About

RayThera is developing small molecule drug candidates for unmet needs in immunology. Its products are intended for healthcare providers and patients. Founded in 2023 in San Diego, US, the company raised USD 110.000 mn in Series A funding in April 2025 from Foresite Capital, OrbiMed Advisors, and Together To Miracle Capital.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in